Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Oncological Medicine
Volume 2015 (2015), Article ID 472037, 5 pages
http://dx.doi.org/10.1155/2015/472037
Case Report

A Case Report of Long-Term Survival following Hepatic Arterial Infusion of L-Folinic Acid Modulated 5-Fluorouracil Combined with Intravenous Irinotecan and Cetuximab Followed by Hepatectomy in a Patient with Initially Unresectable Colorectal Liver Metastases

1Department of Surgery, Laarbeeklaan 101, 1090 Brussels, Belgium
2Department of Medical Oncology, Laarbeeklaan 101, 1090 Brussels, Belgium
3Department of Radiotherapy, Laarbeeklaan 101, 1090 Brussels, Belgium

Received 18 January 2015; Accepted 22 April 2015

Academic Editor: Raffaele Palmirotta

Copyright © 2015 Kobe Van Bael et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. E. van Cutsem, C.-H. Köhne, I. Láng et al., “Cetuximab plus irinotecan, fluorouracil, and leucovorin as first-line treatment for metastatic colorectal cancer: updated analysis of overall survival according to tumor KRAS and BRAF mutation status,” Journal of Clinical Oncology, vol. 29, no. 15, pp. 2011–2019, 2011. View at Publisher · View at Google Scholar · View at Scopus
  2. J. S. Tomlinson, W. R. Jarnagin, R. P. DeMatteo et al., “Actual 10-year survival after resection of colorectal liver metastases defines cure,” Journal of Clinical Oncology, vol. 25, no. 29, pp. 4575–4580, 2007. View at Publisher · View at Google Scholar · View at Scopus
  3. B. Nordlinger, H. Sorbye, B. Glimelius et al., “Perioperative FOLFOX4 chemotherapy and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC 40983): long-term results of a randomised, controlled, phase 3 trial,” The Lancet Oncology, vol. 14, no. 12, pp. 1208–1215, 2013. View at Publisher · View at Google Scholar · View at Scopus
  4. E. K. Abdalla, J.-N. Vauthey, L. M. Ellis et al., “Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection/ablation for colorectal liver metastases,” Annals of Surgery, vol. 239, no. 6, pp. 818–827, 2004. View at Publisher · View at Google Scholar · View at Scopus
  5. R. M. Goldberg, “Therapy for metastatic colorectal cancer,” Oncologist, vol. 11, no. 9, pp. 981–987, 2006. View at Publisher · View at Google Scholar · View at Scopus
  6. J.-N. Vauthey, T. M. Pawlik, D. Ribero et al., “Chemotherapy regimen predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic colorectal metastases,” Journal of Clinical Oncology, vol. 24, no. 13, pp. 2065–2072, 2006. View at Publisher · View at Google Scholar · View at Scopus
  7. R. Adam, V. Delvart, G. Pascal et al., “Rescue surgery for unresectable colorectal liver metastases downstaged by chemotherapy: a model to predict long-term survival,” Annals of Surgery, vol. 240, no. 4, pp. 644–658, 2004. View at Publisher · View at Google Scholar · View at Scopus
  8. S. Benoist, A. Brouquet, C. Penna et al., “Complete response of colorectal liver metastases after chemotherapy: does it mean cure?” Journal of Clinical Oncology, vol. 24, no. 24, pp. 3939–3945, 2006. View at Publisher · View at Google Scholar · View at Scopus
  9. E. K. Abdalla, R. Adam, A. J. Bilchik, D. Jaeck, J.-N. Vauthey, and D. Mahvi, “Improving resectability of hepatic colorectal metastases: expert consensus statement,” Annals of Surgical Oncology, vol. 13, no. 10, pp. 1271–1280, 2006. View at Publisher · View at Google Scholar · View at Scopus
  10. F. D. Barber, G. Mavligit, and R. Kurzrock, “Hepatic arterial infusion chemotherapy for metastatic colorectal cancer: a concise overview,” Cancer Treatment Reviews, vol. 30, no. 5, pp. 425–436, 2004. View at Publisher · View at Google Scholar · View at Scopus
  11. A. P. Venook, “Induction therapy in patients with metastatic colorectal cancer,” Seminars in Oncology, vol. 30, no. 4, pp. 25–29, 2003. View at Google Scholar · View at Scopus
  12. L. B. Saltz, S. Clarke, E. Díaz-Rubio et al., “Bevacizumab in combination with oxaliplatin-based chemotherapy as first-line therapy in metastatic colorectal cancer: a randomized phase III study,” Journal of Clinical Oncology, vol. 26, no. 12, pp. 2013–2019, 2008. View at Publisher · View at Google Scholar · View at Scopus
  13. H. Hurwitz, L. Fehrenbacher, W. Novotny et al., “Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer,” The New England Journal of Medicine, vol. 350, no. 23, pp. 2335–2342, 2004. View at Publisher · View at Google Scholar · View at Scopus
  14. B. Neyns, M. Aerts, Y. Van Nieuwenhove et al., “Cetuximab with hepatic arterial infusion of chemotherapy for the treatment of colorectal cancer liver metastases,” Anticancer Research, vol. 28, no. 4, pp. 2459–2467, 2008. View at Google Scholar · View at Scopus
  15. Y. Van Nieuwenhove, M. Aerts, B. Neyns, and G. Delvaux, “Techniques for the placement of hepatic artery catheters for regional chemotherapy in unresectable liver metastases,” European Journal of Surgical Oncology, vol. 33, no. 3, pp. 336–340, 2007. View at Publisher · View at Google Scholar · View at Scopus
  16. D. J. Gallagher, M. Capanu, G. Raggio, and N. Kemeny, “Hepatic arterial infusion plus systemic irinotecan in patients with unresectable hepatic metastases from colorectal cancer previously treated with systemic oxaliplatin: a retrospective analysis,” Annals of Oncology, vol. 18, no. 12, pp. 1995–1999, 2007. View at Publisher · View at Google Scholar · View at Scopus
  17. N. E. Kemeny, F. D. Huitzil Melendez, M. Capanu et al., “Conversion to resectability using hepatic artery infusion plus systemic chemotherapy for the treatment of unresectable liver metastases from colorectal carcinoma,” Journal of Clinical Oncology, vol. 27, no. 21, pp. 3465–3471, 2009. View at Publisher · View at Google Scholar · View at Scopus
  18. J. B. Ammori, N. E. Kemeny, Y. Fong et al., “Conversion to complete resection and/or ablation using hepatic artery infusional chemotherapy in patients with unresectable liver metastases from colorectal cancer: a decade of experience at a single institution,” Annals of Surgical Oncology, vol. 20, no. 9, pp. 2901–2907, 2013. View at Publisher · View at Google Scholar · View at Scopus
  19. K. van Bael, M. Aerts, M. de Ridder, J. de Gréve, G. Delvaux, and B. Neyns, “Durable remission of inoperable liver metastasis from rectal cancer after hepatic arterial infusion of oxaliplatin and 5-fluorouracil in combination with intravenous cetuximab,” Current Oncology, vol. 18, no. 5, pp. E256–E259, 2011. View at Google Scholar · View at Scopus
  20. R. Kim, “Cetuximab and panitumumab: are they interchangeable?” The Lancet Oncology, vol. 10, no. 12, pp. 1140–1141, 2009. View at Publisher · View at Google Scholar · View at Scopus